Literature DB >> 21495116

Cognitive status correlates with white matter alteration in Parkinson's disease.

Takaaki Hattori1, Satoshi Orimo, Shigeki Aoki, Kenji Ito, Osamu Abe, Atsushi Amano, Ryo Sato, Kasumi Sakai, Hidehiro Mizusawa.   

Abstract

Patients with Parkinson's disease (PD) can develop mild cognitive impairment (PD-MCI), frequently progressing to dementia (PDD). Here, we aimed to elucidate the relationship between white matter alteration and cognitive status in PD and dementia with Lewy bodies (DLB) by using diffusion tensor imaging. We also compared the progression patterns of white and gray matter and the cerebral perfusion. We enrolled patients with PD cognitively normal (PD-CogNL, n = 32), PD-MCI (n = 28), PDD (n = 25), DLB (n = 29), and age- and sex-matched healthy control subjects (n = 40). Fractional anisotropy (FA) map of a patient group was compared with that of control subjects by using tract-based spatial statistics. For the patient cohort, intersubject voxel-wise correlation was performed between FA values and Mini-Mental Status Examination (MMSE) scores. We also evaluated the gray matter and the cerebral perfusion by conducting a voxel-based analysis. There were significantly decreased FA values in many major tracts in patients with PD-MCI, PDD, and DLB, but not in PD-CogNL, compared with control subjects. FA values in the certain white matter areas, particularly the bilateral parietal white matter, were significantly correlated with MMSE scores in patients with PD. Patients with PDD and DLB had diffuse gray matter atrophy. All patient groups had occipital and posterior parietal hypoperfusion when compared with control subjects. Our results suggest that white matter damage underlies cognitive impairment in PD, and cognitive impairment in PD progresses with functional alteration (hypoperfusion) followed by structural alterations in which white matter alteration precedes gray matter atrophy.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21495116      PMCID: PMC6870034          DOI: 10.1002/hbm.21245

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  47 in total

1.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm.

Authors:  Y Zhang; M Brady; S Smith
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  Nonrigid registration using free-form deformations: application to breast MR images.

Authors:  D Rueckert; L I Sonoda; C Hayes; D L Hill; M O Leach; D J Hawkes
Journal:  IEEE Trans Med Imaging       Date:  1999-08       Impact factor: 10.048

3.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

4.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

5.  Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease.

Authors:  J E Lee; H-J Park; S K Song; Y H Sohn; J D Lee; P H Lee
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

6.  White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.

Authors:  Turi O Dalaker; Jan P Larsen; Michael G Dwyer; Dag Aarsland; Mona K Beyer; Guido Alves; Kolbjorn Bronnick; Ole-Bjorn Tysnes; Robert Zivadinov
Journal:  Neuroimage       Date:  2009-06-16       Impact factor: 6.556

7.  Lewy body cortical involvement may not always predict dementia in Parkinson's disease.

Authors:  C Colosimo; A J Hughes; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

8.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

9.  Degeneration of dementia with Lewy bodies measured by diffusion tensor imaging.

Authors:  Miho Ota; Noriko Sato; Masafumi Ogawa; Miho Murata; Sadako Kuno; Jiro Kida; Takashi Asada
Journal:  NMR Biomed       Date:  2009-04       Impact factor: 4.044

10.  Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data.

Authors:  Stephen M Smith; Mark Jenkinson; Heidi Johansen-Berg; Daniel Rueckert; Thomas E Nichols; Clare E Mackay; Kate E Watkins; Olga Ciccarelli; M Zaheer Cader; Paul M Matthews; Timothy E J Behrens
Journal:  Neuroimage       Date:  2006-04-19       Impact factor: 6.556

View more
  90 in total

1.  Longitudinal white matter microstructural change in Parkinson's disease.

Authors:  Vincent Pozorski; Jennifer M Oh; Nagesh Adluru; Andrew P Merluzzi; Frances Theisen; Ozioma Okonkwo; Amy Barzgari; Stephanie Krislov; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Andrew L Alexander; Catherine L Gallagher
Journal:  Hum Brain Mapp       Date:  2018-06-27       Impact factor: 5.038

2.  Neural correlates of distinct cognitive phenotypes in early Parkinson's disease.

Authors:  Ece Bayram; Brent Bluett; Xiaowei Zhuang; Dietmar Cordes; Denise R LaBelle; Sarah J Banks
Journal:  J Neurol Sci       Date:  2019-02-07       Impact factor: 3.181

3.  The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.

Authors:  Dilek Betul Arslan; Hakan Gurvit; Ozan Genc; Ani Kicik; Kardelen Eryurek; Sevim Cengiz; Emel Erdogdu; Zerrin Yildirim; Zeynep Tufekcioglu; Aziz Müfit Uluğ; Basar Bilgic; Hasmet Hanagasi; Erdem Tuzun; Tamer Demiralp; Esin Ozturk-Isik
Journal:  J Neural Transm (Vienna)       Date:  2020-07-06       Impact factor: 3.575

4.  Cortical gray and subcortical white matter associations in Parkinson's disease.

Authors:  Nicholas W Sterling; Guangwei Du; Mechelle M Lewis; Steven Swavely; Lan Kong; Martin Styner; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2016-09-28       Impact factor: 4.673

5.  DTI correlates of distinct cognitive impairments in Parkinson's disease.

Authors:  Zhong Zheng; Shirag Shemmassian; Christopher Wijekoon; Won Kim; Susan Y Bookheimer; Nader Pouratian
Journal:  Hum Brain Mapp       Date:  2013-02-18       Impact factor: 5.038

Review 6.  The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging.

Authors:  Nicola J Ray; Antonio P Strafella
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

7.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

8.  Microstructural white matter alterations in patients with drug induced parkinsonism.

Authors:  Yoonju Lee; Yong Ho Choi; Jae Jung Lee; Hye Sun Lee; Young H Sohn; Jong-Min Lee; Phil Hyu Lee
Journal:  Hum Brain Mapp       Date:  2017-09-12       Impact factor: 5.038

Review 9.  Dementia and neuroimaging.

Authors:  Federica Agosta; Francesca Caso; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-15       Impact factor: 4.849

10.  A preliminary diffusional kurtosis imaging study of Parkinson disease: comparison with conventional diffusion tensor imaging.

Authors:  Koji Kamagata; Hiroyuki Tomiyama; Taku Hatano; Yumiko Motoi; Osamu Abe; Keigo Shimoji; Kouhei Kamiya; Michimasa Suzuki; Masaaki Hori; Mariko Yoshida; Nobutaka Hattori; Shigeki Aoki
Journal:  Neuroradiology       Date:  2014-01-28       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.